Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:10195883rdf:typepubmed:Citationlld:pubmed
pubmed-article:10195883lifeskim:mentionsumls-concept:C0007600lld:lifeskim
pubmed-article:10195883lifeskim:mentionsumls-concept:C1506928lld:lifeskim
pubmed-article:10195883lifeskim:mentionsumls-concept:C1705438lld:lifeskim
pubmed-article:10195883lifeskim:mentionsumls-concept:C0007137lld:lifeskim
pubmed-article:10195883lifeskim:mentionsumls-concept:C0460004lld:lifeskim
pubmed-article:10195883lifeskim:mentionsumls-concept:C0151686lld:lifeskim
pubmed-article:10195883lifeskim:mentionsumls-concept:C1326205lld:lifeskim
pubmed-article:10195883lifeskim:mentionsumls-concept:C1518174lld:lifeskim
pubmed-article:10195883lifeskim:mentionsumls-concept:C1274040lld:lifeskim
pubmed-article:10195883lifeskim:mentionsumls-concept:C1517499lld:lifeskim
pubmed-article:10195883pubmed:issue2lld:pubmed
pubmed-article:10195883pubmed:dateCreated1999-6-7lld:pubmed
pubmed-article:10195883pubmed:abstractTextE2F-1, a transcription factor by discovery, is thought to play a crucial role in regulating G1/S cell cycle progression. Its activity is modulated by complex formation with the retinoblastoma protein and related proteins. Overexpression of E2F-1 has been shown to induce apoptosis in quiescent fibroblasts. We constructed a recombinant E2F-1 adenovirus to test whether an overexpression of E2F-1 in head and neck squamous cell carcinoma cell lines would also induce apoptosis. Two cell lines, Tu-138 and Tu-167, were chosen for use in this study. Both cell lines harbor p53 mutations but express different levels of the retinoblastoma protein. Upon E2F-1 adenovirus infection, both cell lines expressed elevated levels of E2F-1 protein and then activated a pRb-chloramphenicol acetyltransferase reporter construct containing an E2F-1 binding motif. In vitro growth assay demonstrated that growth suppression by the E2F-1 protein was effective on both cell lines. Results from DNA fragmentation and terminal deoxynucleotidyl transferase-mediated deoxyuridine triphosphate-biotin nick end-labeling analyses indicated apoptosis induction in cells infected with AdCMV-E2F-1. Moreover, ex vivo experiments in nude mice showed total suppression of tumor growth at sites that received cells infected AdCMV-E2F-1. An in vivo analysis of apoptosis using in situ end-labeling further demonstrated the induction of apoptosis by AdCMV-E2F-1 in tumor-bearing animals. These data indicate that overexpression of E2F-1 via an adenoviral vector suppresses in vitro and in vivo growth of head and neck squamous carcinoma cell lines through induction of apoptosis.lld:pubmed
pubmed-article:10195883pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10195883pubmed:languageenglld:pubmed
pubmed-article:10195883pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10195883pubmed:citationSubsetIMlld:pubmed
pubmed-article:10195883pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10195883pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10195883pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10195883pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10195883pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10195883pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10195883pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10195883pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10195883pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10195883pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10195883pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10195883pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10195883pubmed:statusMEDLINElld:pubmed
pubmed-article:10195883pubmed:issn0929-1903lld:pubmed
pubmed-article:10195883pubmed:authorpubmed-author:WangMMlld:pubmed
pubmed-article:10195883pubmed:authorpubmed-author:DAWH THTlld:pubmed
pubmed-article:10195883pubmed:authorpubmed-author:ClaymanG LGLlld:pubmed
pubmed-article:10195883pubmed:authorpubmed-author:El-NaggarA...lld:pubmed
pubmed-article:10195883pubmed:authorpubmed-author:HendersonYYlld:pubmed
pubmed-article:10195883pubmed:authorpubmed-author:SteckK DKDlld:pubmed
pubmed-article:10195883pubmed:authorpubmed-author:BreauR LRLlld:pubmed
pubmed-article:10195883pubmed:authorpubmed-author:SicardM WMWlld:pubmed
pubmed-article:10195883pubmed:issnTypePrintlld:pubmed
pubmed-article:10195883pubmed:volume6lld:pubmed
pubmed-article:10195883pubmed:ownerNLMlld:pubmed
pubmed-article:10195883pubmed:authorsCompleteYlld:pubmed
pubmed-article:10195883pubmed:pagination163-71lld:pubmed
pubmed-article:10195883pubmed:dateRevised2009-11-19lld:pubmed
pubmed-article:10195883pubmed:meshHeadingpubmed-meshheading:10195883...lld:pubmed
pubmed-article:10195883pubmed:meshHeadingpubmed-meshheading:10195883...lld:pubmed
pubmed-article:10195883pubmed:meshHeadingpubmed-meshheading:10195883...lld:pubmed
pubmed-article:10195883pubmed:meshHeadingpubmed-meshheading:10195883...lld:pubmed
pubmed-article:10195883pubmed:meshHeadingpubmed-meshheading:10195883...lld:pubmed
pubmed-article:10195883pubmed:meshHeadingpubmed-meshheading:10195883...lld:pubmed
pubmed-article:10195883pubmed:meshHeadingpubmed-meshheading:10195883...lld:pubmed
pubmed-article:10195883pubmed:meshHeadingpubmed-meshheading:10195883...lld:pubmed
pubmed-article:10195883pubmed:meshHeadingpubmed-meshheading:10195883...lld:pubmed
pubmed-article:10195883pubmed:meshHeadingpubmed-meshheading:10195883...lld:pubmed
pubmed-article:10195883pubmed:meshHeadingpubmed-meshheading:10195883...lld:pubmed
pubmed-article:10195883pubmed:meshHeadingpubmed-meshheading:10195883...lld:pubmed
pubmed-article:10195883pubmed:meshHeadingpubmed-meshheading:10195883...lld:pubmed
pubmed-article:10195883pubmed:meshHeadingpubmed-meshheading:10195883...lld:pubmed
pubmed-article:10195883pubmed:meshHeadingpubmed-meshheading:10195883...lld:pubmed
pubmed-article:10195883pubmed:meshHeadingpubmed-meshheading:10195883...lld:pubmed
pubmed-article:10195883pubmed:meshHeadingpubmed-meshheading:10195883...lld:pubmed
pubmed-article:10195883pubmed:meshHeadingpubmed-meshheading:10195883...lld:pubmed
pubmed-article:10195883pubmed:meshHeadingpubmed-meshheading:10195883...lld:pubmed
pubmed-article:10195883pubmed:meshHeadingpubmed-meshheading:10195883...lld:pubmed
pubmed-article:10195883pubmed:meshHeadingpubmed-meshheading:10195883...lld:pubmed
pubmed-article:10195883pubmed:meshHeadingpubmed-meshheading:10195883...lld:pubmed
pubmed-article:10195883pubmed:meshHeadingpubmed-meshheading:10195883...lld:pubmed
pubmed-article:10195883pubmed:meshHeadingpubmed-meshheading:10195883...lld:pubmed
pubmed-article:10195883pubmed:meshHeadingpubmed-meshheading:10195883...lld:pubmed
pubmed-article:10195883pubmed:articleTitleApoptosis induction by E2F-1 via adenoviral-mediated gene transfer results in growth suppression of head and neck squamous cell carcinoma cell lines.lld:pubmed
pubmed-article:10195883pubmed:affiliationDepartment of Head and Neck Surgery, University of Texas M.D. Anderson Cancer Center, Houston 77303, USA. tjlui@notes.mdacc.tmc.edulld:pubmed
pubmed-article:10195883pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:10195883pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
pubmed-article:10195883pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10195883lld:pubmed